FATE financials

Fate Therapeutics (FATE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

FATE income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$6.65M–-$147.70M-$136.31M-1.15
2024$13.63M–-$210.28M-$186.26M-1.64
2023$63.53M–-$190.51M-$160.93M-1.64
2022$96.30M–-$308.39M-$281.72M-2.91
2021$55.85M–-$216.99M-$212.15M-2.24
2020$31.43M–-$128.09M-$173.39M-2.10